Clinical Trial Update: Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating recombinant human endostatin in combination with CV regimen for pediatric low-grade gliomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Low-grade Glioma

Drugs mentioned

• CV regimen
• Recombinant human endostatin (recombinant human endostatin)

Snippet

Sponsor: Beijing Sanbo Brain Hospital | Conditions: Low-grade Glioma, Pediatric Brain Tumor | Phase 2 | Status: COMPLETED